Male germ cell-associated kinase is overexpressed in prostate cancer cells and causes mitotic defects via deregulation of APC/C CDH1

Oncogene

Volumn 31, Issue 24, 2012, Pages 2907-2918

  Wang, L Y ^a   Kung, H J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

APC C complex; CDH1 FZR1; MAK; mitosis; prostate cancer

Indexed keywords

ANAPHASE PROMOTING COMPLEX; ANDROGEN RECEPTOR; AURORA A KINASE; CELL CYCLE PROTEIN 20; CYCLIN DEPENDENT KINASE; LIGASE; MALE GERM CELL ASSOCIATED KINASE; POLO LIKE KINASE 1; PROTEIN KINASE; UBIQUITIN C; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL CYCLE; CENTROSOME; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE OVEREXPRESSION; GERM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MITOSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

AMINO ACID MOTIFS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL INSTABILITY; CYCLIN-DEPENDENT KINASES; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MITOSIS; PHOSPHORYLATION; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, ANDROGEN; UBIQUITIN-PROTEIN LIGASE COMPLEXES; UBIQUITIN-PROTEIN LIGASES;

EID: 84862309940     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.464     Document Type: Article

References (43)

1. Beheshti B, Park PC, Sweet JM, Trachtenberg J, Jewett MA, Squire JA. (2001). Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase fish analysis. Neoplasia 3: 62-69. (Pubitemid 32201611)
2. Bolte M, Steigemann P, Braus GH, Irniger S. (2002). Inhibition of APC-mediated proteolysis by the meiosis-specific protein kinase Ime2. Proc Natl Acad Sci USA 99: 4385-4390. (Pubitemid 34285994)
3. Brown NR, Noble ME, Lawrie AM, Morris MC, Tunnah P, Divita G et al. (1999). Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. J Biol Chem 274: 8746-8756. (Pubitemid 29164672)
4. Buschhorn HM, Klein RR, Chambers SM, Hardy MC, Green S, Bearss D et al. (2005). Aurora-A over-expression in high-grade PIN lesions and prostate cancer. Prostate 64: 341-346. (Pubitemid 41193246)
5. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R et al. (2004). Molecular determinants of resistance to antiandrogen therapy. Nat Med 10: 33-39. (Pubitemid 38524696)
6. Clark JP, Cooper CS. (2009). ETS gene fusions in prostate cancer. Nat Rev Urol 6: 429-439.
7. Engelbert D, Schnerch D, Baumgarten A, Wasch R. (2008). The ubiquitin ligase APC(Cdh1) is required to maintain genome integrity in primary human cells. Oncogene 27: 907-917. (Pubitemid 351225382)
8. Feldman BJ, Feldman D. (2001). The development of androgen-independent prostate cancer. Nat Rev Cancer 1: 34-45. (Pubitemid 33741879)
9. Fu Z, Larson KA, Chitta RK, Parker SA, Turk BE, Lawrence MW et al. (2006). Identification of yin-yang regulators and a phosphorylation consensus for male germ cell-associated kinase (MAK)-related kinase. Mol Cell Biol 26: 8639-8654. (Pubitemid 44748594)
10. Fu Z, Schroeder MJ, Shabanowitz J, Kaldis P, Togawa K, Rustgi AK et al. (2005). Activation of a nuclear Cdc2-related kinase within a mitogen-activated protein kinase-like TDY motif by autophosphorylation and cyclin-dependent protein kinase-activating kinase. Mol Cell Biol 25: 6047-6064. (Pubitemid 40946557)
11. Ganem NJ, Godinho SA, Pellman D. (2009). A mechanism linking extra centrosomes to chromosomal instability. Nature 460: 278-282.
12. Garcia-Higuera I, Manchado E, Dubus P, Canamero M, Mendez J, Moreno S et al. (2008). Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat Cell Biol 10: 802-811. (Pubitemid 351927709)
13. Gibas Z, Becher R, Kawinski E, Horoszewicz J, Sandberg AA. (1984). A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP). Cancer Genet Cytogenet 11: 399-404. (Pubitemid 14107791)
14. Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, French FS et al. (2001). A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 61: 4315-4319. (Pubitemid 32685750)
15. Holt LJ, Hutti JE, Cantley LC, Morgan DO. (2007). Evolution of Ime2 phosphorylation sites on Cdk1 substrates provides a mechanism to limit the effects of the phosphatase Cdc14 in meiosis. Mol Cell 25: 689-702. (Pubitemid 46341927)
16. Honigberg SM. (2004). Ime2p and Cdc28p: co-pilots driving meiotic development. J Cell Biochem 92: 1025-1033.
17. Jaspersen SL, Charles JF, Morgan DO. (1999). Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14. Curr Biol 9: 227-236. (Pubitemid 29139305)
18. Koji T, Jinno A, Matsushime H, Shibuya M, Nakane PK. (1992). In situ localization of male germ cell-associated kinase (mak) mRNA in adult mouse testis: specific expression in germ cells at stages around meiotic cell division. Cell Biochem Funct 10: 273-279.
19. Kraft C, Vodermaier HC, Maurer-Stroh S, Eisenhaber F, Peters JM. (2005). The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates. Mol Cell 18: 543-553. (Pubitemid 40726231)
20. Kramer ER, Scheuringer N, Podtelejnikov AV, Mann M, Peters JM. (2000). Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol Biol Cell 11: 1555-1569. (Pubitemid 30307896)
21. Lukas C, Sorensen CS, Kramer E, Santoni-Rugiu E, Lindeneg C, Peters JM et al. (1999). Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature 401: 815-818.
22. Ma AH, Xia L, Desai SJ, Boucher DL, Guan Y, Shih HM et al. (2006). Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells. Cancer Res 66: 8439-8447. (Pubitemid 44449155)
23. Matsushime H, Jinno A, Takagi N, Shibuya M. (1990). A novel mammalian protein kinase gene (mak) is highly expressed in testicular germ cells at and after meiosis. Mol Cell Biol 10: 2261-2268.
24. Mendiratta P, Mostaghel E, Guinney J, Tewari AK, Porrello A, Barry WT et al. (2009). Genomic strategy for targeting therapy in castration-resistant prostate cancer. J Clin Oncol 27: 2022-2029.
25. Ouyang X, Wang X, Xu K, Jin DY, Cheung AL, Tsao SW et al. (2001). Effect of p53 on centrosome amplification in prostate cancer cells. Biochim Biophys Acta 1541: 212-220. (Pubitemid 34045128)
26. Pan Y, Kytola S, Farnebo F, Wang N, Lui WO, Nupponen N et al. (1999). Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping. Cytogenet Cell Genet 87: 225-232. (Pubitemid 30103099)
27. Payne DM, Rossomando AJ, Martino P, Erickson AK, Her JH, Shabanowitz J et al. (1991). Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). Embo J 10: 885-892. (Pubitemid 21905546)
28. Pfleger CM, Salic A, Lee E, Kirschner MW. (2001). Inhibition of Cdh1-APC by the MAD2-related protein MAD2L2: a novel mechanism for regulating Cdh1. Genes Dev 15: 1759-1764. (Pubitemid 32905633)
29. Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, Doxsey SJ. (2001). Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 61: 2212-2219. (Pubitemid 32692050)
30. Reimann JD, Gardner BE, Margottin-Goguet F, Jackson PK. (2001). Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins. Genes Dev 15: 3278-3285. (Pubitemid 34013499)
31. Robinson D, He F, Pretlow T, Kung HJ. (1996). A tyrosine kinase profile of prostate carcinoma. Proc Natl Acad Sci USA 93: 5958-5962. (Pubitemid 26190784)
32. Roh M, Gary B, Song C, Said-Al-Naief N, Tousson A, Kraft A et al. (2003). Overexpression of the oncogenic kinase Pim-1 leads to genomic instability. Cancer Res 63: 8079-8084. (Pubitemid 37549449)
33. Ross KE, Cohen-Fix O. (2003). The role of Cdh1p in maintaining genomic stability in budding yeast. Genetics 165: 489-503. (Pubitemid 37337619)
34. Shand RL, Gelmann EP. (2006). Molecular biology of prostate-cancer pathogenesis. Curr Opin Urol 16: 123-131. (Pubitemid 43791779)
35. Tribukait B. (1991). DNA flow cytometry in carcinoma of the prostate for diagnosis, prognosis and study of tumor biology. Acta Oncol 30: 187-192.
36. Wang X, Di K, Zhang X, Han HY, Wong YC, Leung SC et al. (2008). Id-1 promotes chromosomal instability through modification of APC/C activity during mitosis in response to microtubule disruption. Oncogene 27: 4456-4466.
37. Wasch R, Engelbert D. (2005). Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cells. Oncogene 24: 1-10. (Pubitemid 40143858)
38. Weichert W, Schmidt M, Gekeler V, Denkert C, Stephan C, Jung K et al. (2004). Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate 60: 240-245. (Pubitemid 38971835)
39. Wohlbold L, Larochelle S, Liao JC, Livshits G, Singer J, Shokat KM et al. (2006). The cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activity. Cell Cycle 5: 546-554. (Pubitemid 43340534)
40. Xia L, Robinson D, Ma AH, Chen HC, Wu F, Qiu Y et al. (2002). Identification of human male germ cell-associated kinase, a kinase transcriptionally activated by androgen in prostate cancer cells. J Biol Chem 277: 35422-35433.
41. Zachariae W, Schwab M, Nasmyth K, Seufert W. (1998). Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex. Science 282: 1721-1724. (Pubitemid 28549290)
42. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A et al. (1998). Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20: 189-193. (Pubitemid 28455454)
43. Zhou Y, Ching YP, Chun AC, Jin DY. (2003). Nuclear localization of the cell cycle regulator CDH1 and its regulation by phosphorylation. J Biol Chem 278: 12530-12536. (Pubitemid 36800242)